Works matching AU Link, Jeanne


Results: 58
    1

    NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies.

    Published in:
    2009
    By:
    • Spence, Alexander;
    • Muzi, Mark;
    • Link, Jeanne;
    • O’Sullivan, Finbarr;
    • Eary, Janet;
    • Hoffman, John;
    • Shankar, Lalitha;
    • Krohn, Kenneth;
    • Spence, Alexander M;
    • Link, Jeanne M;
    • O'Sullivan, Finbarr;
    • Eary, Janet F;
    • Hoffman, John M;
    • Shankar, Lalitha K;
    • Krohn, Kenneth A
    Publication type:
    journal article
    2
    3

    Book Reviews.

    Published in:
    1996
    By:
    • Albrecht, Don E.;
    • Carr, Ana R.;
    • Dunham, Carolyn S.;
    • Gieseke, Joy A.;
    • Imerman, Eric B.;
    • Kroma, Margaret M.;
    • Link, Jeanne M.;
    • Petrzelka, Peggy;
    • Ramsey, Melndy A.;
    • Stratton, Kimberly S.;
    • Szymanski, Marcella B.;
    • Tate-Clark, Jeanette L.
    Publication type:
    Book Review
    4
    5
    6
    7
    8

    Kenneth A. Krohn, PhD, 1945–2024.

    Published in:
    Journal of Nuclear Medicine, 2025, v. 66, n. 3, p. 486, doi. 10.2967/jnumed.124.269449
    By:
    • Eary, Janet;
    • Link, Jeanne;
    • Mankoff, David;
    • Vera, David;
    • Ruth, Tom
    Publication type:
    Article
    9

    In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using <sup>11</sup>C-CHDI-180R PET in a Nonhuman Primate Model of Huntington Disease.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1581, doi. 10.2967/jnumed.123.265569
    By:
    • Bertoglio, Daniele;
    • Weiss, Alison R.;
    • Liguore, William;
    • Martin, Lauren Drew;
    • Hobbs, Theodore;
    • Templon, John;
    • Srinivasan, Sathya;
    • Dominguez, Celia;
    • Munoz-Sanjuan, Ignacio;
    • Khetarpal, Vinod;
    • Verhaeghe, Jeroen;
    • Staelens, Steven;
    • Link, Jeanne;
    • Liu, Longbin;
    • Bard, Jonathan A.;
    • McBride, Jodi L.
    Publication type:
    Article
    10

    <sup>18</sup>F-Fluoroestradiol (<sup>18</sup>F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244459
    By:
    • Peterson, Lanell M.;
    • Kurland, Brenda F.;
    • Fengting Yan;
    • Novakova-Jiresova, Alena;
    • Gadi, Vijayakrishna K.;
    • Specht, Jennifer M.;
    • Gralow, Julie R.;
    • Schubert, Erin K.;
    • Link, Jeanne M.;
    • Krohn, Kenneth A.;
    • Eary, Janet F.;
    • Mankoff, David A.;
    • Linden, Hannah M.
    Publication type:
    Article
    11

    <sup>18</sup>F-Fluoroestradiol (18F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244459
    By:
    • Peterson, Lanell M.;
    • Kurland, Brenda F.;
    • Fengting Yan;
    • Novakova-Jiresova, Alena;
    • Gadi, Vijayakrishna K.;
    • Specht, Jennifer M.;
    • Gralow, Julie R.;
    • Schubert, Erin K.;
    • Link, Jeanne M.;
    • Krohn, Kenneth A.;
    • Eary, Janet F.;
    • Mankoff, David A.;
    • Linden, Hannah M.
    Publication type:
    Article
    12

    <sup>18</sup>F-Fluoroestradiol (<sup>18</sup>F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.244459
    By:
    • Peterson, Lanell M;
    • Kurland, Brenda F;
    • Yan, Fengting;
    • NovakovaJiresova, Alena;
    • Gadi, Vijayakrishna K;
    • Specht, Jennifer M;
    • Gralow, Julie R;
    • Schubert, Erin K;
    • Link, Jeanne M;
    • Krohn, Kenneth A;
    • Eary, Janet F;
    • Mankoff, David A;
    • Linden, Hannah M
    Publication type:
    Article
    13

    <sup>18</sup>F-Fluoroestradiol (<sup>18</sup>F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.244459
    By:
    • Peterson, Lanell M.;
    • Kurland, Brenda F.;
    • Fengting Yan;
    • Novakova-Jiresova, Alena;
    • Gadi, Vijayakrishna K.;
    • Specht, Jennifer M.;
    • Gralow, Julie R.;
    • Schubert, Erin K.;
    • Link, Jeanne M.;
    • Krohn, Kenneth A.;
    • Eary, Janet F.;
    • Mankoff, David A.;
    • Linden, Hannah M.
    Publication type:
    Article
    14

    <sup>18</sup>F-Fluoroestradiol (<sup>18</sup>F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2-metastatic breast cancer.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.244459
    By:
    • Peterson, Lanell M.;
    • Kurland, Brenda F.;
    • Fengting Yan;
    • Novakova-Jiresova, Alena;
    • Gadi, Vijayakrishna K.;
    • Specht, Jennifer M.;
    • Gralow, Julie R.;
    • Schubert, Erin K.;
    • Link, Jeanne M.;
    • Krohn, Kenneth A.;
    • Eary, Janet F.;
    • Mankoff, David A.;
    • Linden, Hannah M.
    Publication type:
    Article
    15
    16

    The Future of USP Monographs for PET Drugs.

    Published in:
    Journal of Nuclear Medicine, 2013, v. 54, n. 3, p. 472, doi. 10.2967/jnumed.112.115089
    By:
    • Schwarz, Sally;
    • Norenberg, Jeffrey;
    • Berridge, Marc;
    • Dragotakes, Stephen;
    • Hung, Joseph;
    • Link, Jeanne;
    • Mason, N. Scott;
    • Mattmuller, Steve;
    • Nickel, Richard A.;
    • Packard, Alan;
    • Paolino, Justin;
    • Petty, Neil;
    • Ponto, James;
    • Quinton, Timothy M.;
    • Seifert, Katherine L.;
    • Swanson, Dennis;
    • Weiner, Ronald E.;
    • Zigler, Steven
    Publication type:
    Article
    17
    18
    19

    Multiagent PET for Risk Characterization in Sarcoma.

    Published in:
    Journal of Nuclear Medicine, 2011, v. 52, n. 4, p. 541, doi. 10.2967/jnumed.110.083717
    By:
    • Eary, Janet F.;
    • Link, Jeanne M.;
    • Muzi, Mark;
    • Conrad, Ernest U.;
    • Mankoff, David A.;
    • White, Jedediah K.;
    • Krohn, Kenneth A.
    Publication type:
    Article
    20
    21
    22

    Tumor Receptor Imaging.

    Published in:
    Journal of Nuclear Medicine, 2008, v. 49, n. 6, p. 149S, doi. 10.2967/jnumed.107.045963
    By:
    • Mankoff, David A.;
    • Link, Jeanne M.;
    • Linden, Hannah M.;
    • Sundararajan, Lavanya;
    • Krohn, Kenneth A.
    Publication type:
    Article
    23

    Molecular Imaging of Hypoxia.

    Published in:
    Journal of Nuclear Medicine, 2008, v. 49, n. 6, p. 129S, doi. 10.2967/jnumed.107.045914
    By:
    • Krohn, Kenneth A.;
    • Link, Jeanne M.;
    • Mason, Ralph P.
    Publication type:
    Article
    24
    25
    26
    27

    Reply.

    Published in:
    2006
    By:
    • Unadkat, Jashvant D.;
    • Link, Jeanne M.;
    • Mankoff, David A.;
    • Muzi, Mark;
    • Collier, Ann C.
    Publication type:
    Letter
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    The FDG Lumped Constant in Normal Human Brain.

    Published in:
    Journal of Nuclear Medicine, 2002, v. 43, n. 9, p. 1157
    By:
    • Graham, Michael M.;
    • Muzi, Mark;
    • Spence, Alexander M.;
    • O'Sullivan, Finbarr;
    • Lewellen, Thomas K.;
    • Link, Jeanne M.;
    • Krohn, Kenneth A.
    Publication type:
    Article
    38
    39
    40
    41

    Carbon- 11-Thymidine and FDG to Measure Therapy Response.

    Published in:
    Journal of Nuclear Medicine, 1998, v. 39, n. 10, p. 1757
    By:
    • Shields, Anthony F.;
    • Mankoff, David A.;
    • Link, Jeanne M.;
    • Graham, Michael M.;
    • Eary, Janet F.;
    • Kozawa, Susie M.;
    • Zheng, Minna;
    • Lewellen, Barbara;
    • Lewellen, Thomas K.;
    • Grierson, John R.;
    • Krohn, Kenneth A.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50